Robert Brown Jr
Overview
Explore the profile of Robert Brown Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
900
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaplan A, Comisar L, Ufere N, Jannat-Khah D, Rosenblatt R, Fortune B, et al.
Clin Gastroenterol Hepatol
. 2022 Jun;
21(4):1005-1012.e4.
PMID: 35643416
Background & Aims: Patients require a clear understanding of their prognosis to make informed decisions about their care. The aim of this study was to compare the perceptions of prognosis...
2.
Lim A, Singhal S, Lavallee P, Amarenco P, Rothwell P, Albers G, et al.
J Stroke Cerebrovasc Dis
. 2020 Oct;
29(11):105228.
PMID: 33066882
Background: This report aims to describe changes that centres providing transient ischaemic attack (TIA) pathway services have made to stay operational in response to the SARS-CoV-2 pandemic. Methods: An international...
3.
Geekiyanage H, Rayatpisheh S, Wohlschlegel J, Brown Jr R, Ambros V
Proc Natl Acad Sci U S A
. 2020 Sep;
117(39):24213-24223.
PMID: 32929008
MicroRNAs (miRNAs) function cell-intrinsically to regulate gene expression by base-pairing to complementary mRNA targets while in association with Argonaute, the effector protein of the miRNA-mediated silencing complex (miRISC). A relatively...
4.
Rosenblatt R, Cohen-Mekelburg S, Shen N, Tafesh Z, Lucero C, Kumar S, et al.
Am J Gastroenterol
. 2019 Jun;
114(9):1488-1495.
PMID: 31180921
Introduction: Although the Hospital Readmissions Reduction Program (HRRP) has decreased readmissions in targeted conditions, outcomes in high-risk subgroups are unknown. This study analyzed the impact of cirrhosis as a comorbidity...
5.
Kwo P, Mantry P, Coakley E, Te H, Vargas H, Brown Jr R, et al.
N Engl J Med
. 2014 Nov;
371(25):2375-82.
PMID: 25386767
Background: Hepatitis C virus (HCV) infection is the leading indication for liver transplantation worldwide, and interferon-containing regimens are associated with low response rates owing to treatment-limiting toxic effects in immunosuppressed...
6.
Curry M, Forns X, Chung R, Terrault N, Brown Jr R, Fenkel J, et al.
Gastroenterology
. 2014 Sep;
148(1):100-107.e1.
PMID: 25261839
Background & Aims: Patients with detectable hepatitis C virus (HCV) RNA at the time of liver transplantation universally experience recurrent HCV infection. Antiviral treatment before transplantation can prevent HCV recurrence,...
7.
Martin P, DiMartini A, Feng S, Brown Jr R, Fallon M
Hepatology
. 2014 Apr;
59(3):1144-65.
PMID: 24716201
No abstract available.
8.
Haramati S, Chapnik E, Sztainberg Y, Eilam R, Zwang R, Gershoni N, et al.
Proc Natl Acad Sci U S A
. 2010 Jul;
107(29):13111-6.
PMID: 20616011
Defective RNA metabolism is an emerging mechanism involved in ALS pathogenesis and possibly in other neurodegenerative disorders. Here, we show that microRNA (miRNA) activity is essential for long-term survival of...
9.
Alkofer B, Samstein B, Guarrera J, Kin C, Jan D, Bellemare S, et al.
Semin Liver Dis
. 2006 Jul;
26(3):221-33.
PMID: 16850371
Extended-donor criteria liver allografts do not meet traditional criteria for transplantation. Although these organs offer immediate expansion of the donor pool, transplantation of extended-donor criteria liver allografts increases potential short-...
10.
Renz J, Kin C, Kinkhabwala M, Jan D, Varadarajan R, Goldstein M, et al.
Ann Surg
. 2005 Sep;
242(4):556-63.
PMID: 16192816
Objective: The objective of this study was to evaluate the effect of systematic utilization of extended donor criteria liver allografts (EDC), including living donor allografts (LDLT), on patient access to...